Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

Ni,Lina; Li,Chuanbao; Li,Yingbo

doi:10.3892/ol.2020.11257

Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

Authors:
- Lina Ni
- Chuanbao Li
- Yingbo Li
View Affiliations

Affiliations: Department of Blood Transfusion, Weihai Central Hospital, Wendeng, Weihai, Shandong 264400, P.R. China, Department of Hepatobiliary Surgery, Weihai Central Hospital, Wendeng, Weihai, Shandong 264400, P.R. China
Published online on: January 24, 2020 https://doi.org/10.3892/ol.2020.11257
Pages: 2562-2567

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and its expression in chronic hepatitis B, liver cirrhosis and liver cancer were investigated to evaluated the significance of APOBEC3G. Fifty-eight patients with chronic hepatitis B were selected, including 20 cases of chronic hepatitis B, 19 cases of liver cirrhosis and 19 cases of liver cancer. Liver function indexes were detected and analyzed, and messenger ribonucleic acid (mRNA) and protein expression levels of APOBEC3G in liver tissues were detected via reverse transcription-polymerase chain reaction (RT-PCR), western blotting and immunohistochemistry, followed by correlation analysis. Certain liver function indexes had significant differences among the three groups of patients (P<0.05). Results of RT-PCR, Western blotting and immunohistochemistry confirmed that the content of APOBEC3G in liver tissues was the highest in patients with chronic hepatitis B, slightly lower in patients with liver cirrhosis and the lowest in patients with liver cancer. The content of APOBEC3G mRNA in liver tissues had a certain correlation with the content of alanine aminotransferase (ALT) (r2=0.34, P<0.05). Other liver function indexes had no significant correlations with APOBEC3G (P>0.05). APOBEC3G expression has a certain correlation with some liver function indexes of patients with chronic hepatitis B. There are significant differences in the expression level of APOBEC3G in patients with hepatitis, liver cirrhosis and liver cancer.

View Figures

View References

1	Gerlich WH: Medical virology of hepatitis B: How it began and where we are now. Virol J. 10:2392013.PubMed/NCBI
2	Teng B, Burant CF and Davidson NO: Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260:1816–1819. 1993.PubMed/NCBI
3	Wedekind JE, Dance GS, Sowden MP and Smith HC: Messenger RNA editing in mammals: New members of the APOBEC family seeking roles in the family business. Trends Genet. 19:207–216. 2003.PubMed/NCBI
4	Deng Y, Du Y, Zhang Q, Han X and Cao G: Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. Cancer Lett. 343:161–171. 2014.PubMed/NCBI
5	Nguyen DH, Gummuluru S and Hu J: Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol. 81:4465–4472. 2007.PubMed/NCBI
6	Rösler C, Köck J, Kann M, Malim MH, Blum HE, Baumert TF and von Weizsäcker F: APOBEC-mediated interference with hepadnavirus production. Hepatology. 42:301–309. 2005.PubMed/NCBI
7	Koning FA, Newman EN, Kim EY, Kunstman KJ, Wolinsky SM and Malim MH: Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol. 83:9474–9485. 2009.PubMed/NCBI
8	Vartanian JP, Henry M, Marchio A, Suspène R, Aynaud MM, Guétard D, Cervantes-Gonzalez M, Battiston C, Mazzaferro V, Pineau P, et al: Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog. 6:e10009282010.PubMed/NCBI
9	Turelli P, Mangeat B, Jost S, Vianin S and Trono D: Inhibition of hepatitis B virus replication by APOBEC3G. Science. 303:18292004.PubMed/NCBI
10	Köck J and Blum HE: Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J Gen Virol. 89:1184–1191. 2008.PubMed/NCBI
11	Henry M, Guétard D, Suspène R, Rusniok C, Wain-Hobson S and Vartanian JP: Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS One. 4:e42772009.PubMed/NCBI
12	Suspène R, Guétard D, Henry M, Sommer P, Wain-Hobson S and Vartanian JP: Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA. 102:8321–8326. 2005.PubMed/NCBI
13	Soros VB and Greene WC: APOBEC3G and HIV-1: Strike and counterstrike. Curr Infect Dis Rep. 8:317–323. 2006.PubMed/NCBI
14	Chiu YL and Greene WC: Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol. 27:291–297. 2006.PubMed/NCBI
15	Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, Freed EO, Hu WS and Pathak VK: Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J Biol Chem. 279:35822–35828. 2004.PubMed/NCBI
16	Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, Candinas D, Sommer P, Wain-Hobson S, Vartanian JP, et al: Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology. 43:1364–1374. 2006.PubMed/NCBI
17	El-Zayadi AR: Hepatitis B virus infection: The Egyptian situation. Arab J Gastroenterol. 8:94–98. 2007.
18	Guan R, Yap I, Wong L, Tan LH, Oon CJ and Wee A: Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: Measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA). Ann Acad Med Singapore. 18:8–11, 21989. 1989.PubMed/NCBI
19	Zhao D, Wang X, Lou G, Peng G, Li J, Zhu H, Chen F, Li S, Liu D, Chen Z, et al: APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems. Virus Res. 151:213–219. 2010.PubMed/NCBI
20	Stenglein MD, Burns MB, Li M, Lengyel J and Harris RS: APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol. 17:222–229. 2010.PubMed/NCBI
21	Vartanian JP, Henry M, Marchio A, Suspene R, Aynaud MM, Guetard D, Cervantes-Gonzalez M, Battiston C, Mazzaferro V, Pineau P, et al: Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog. 6:e10009282010.PubMed/NCBI
22	Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, et al: Dual effect of APOBEC3G on Hepatitis B virus. J Gen Virol. 88:432–440. 2007.PubMed/NCBI
23	Seppen J: Unedited inhibition of HBV replication by APOBEC3G. J Hepatol. 41:1068–1069. 2004.PubMed/NCBI
24	Tanaka Y, Marusawa H, Seno H, Matsumoto Y, Ueda Y, Kodama Y, Endo Y, Yamauchi J, Matsumoto T, Takaori-Kondo A, et al: Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem Biophys Res Commun. 341:314–319. 2006.PubMed/NCBI